Académique Documents
Professionnel Documents
Culture Documents
This training plan accompanies the clinical guideline: Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing (available at www.nice.org.u !guidance!"#$%%&. 'ssue date: (une )*$). +pdated ,ctober )*$- to include details of the .'"E /uality standard for management of venous thromboembolic diseases. The guideline has not changed
This is a support tool for implementation of the .'"E guidance. 't is not .'"E guidance. 'mplementation of the guidance is the responsibility of local commissioners and!or providers. "ommissioners and providers are reminded that it is their responsibility to implement this guidance0 in their local conte1t0 in light of their duties to avoid unlawful discrimination and to have regard to promoting e/uality of opportunity. .othing in the guidance should be interpreted in a way that would be inconsistent with compliance with those duties.
What do you think? 2id this tool meet your re/uirements0 and did it help you put the .'"E guidance into practice3 4e value your opinion and are loo ing for ways to improve our tools. Please complete this short evaluation form. 'f you are e1periencing problems using this tool0 please email implementation5nice.org.u .
Contents
"ontents ...............................................................................................................'ntroduction...........................................................................................................% 6earning ob>ectives...............................................................................................? @ey to terms .........................................................................................................? Pre=wor shop /ui8................................................................................................A Pre= wor shop /ui8 /uestions...........................................................................A Pre= wor shop /ui8 answers.............................................................................B .............................................................................................................................C .'"E Pulmonary embolism education and learning resources..........................$* Post=wor shop /ui8.............................................................................................$$ Post=wor shop /ui8 /uestions .......................................................................$$ Post= wor shop /ui8 answers.........................................................................$) Evaluation form...................................................................................................$% "ertificate of attendance.....................................................................................$D ,ther implementation tools.................................................................................)* 7c nowledgements.............................................................................................)*
Introduction
This training plan has been developed to provide the framewor for a wor shop designed to support education and learning about the diagnosis and management of pulmonary embolism (PE&. The plan consists of: 6earning ob>ectives @ey terms Pre=wor shop /ui8 to help assess current nowledge of venous thromboembolic diseases and outcomes. The /ui8 will help identify individual needs that can be aggregated for the group. This will ta e about ? minutes. 2etails of Eignposting to .'"E PE education and learning resources (including the details of how long each resource will ta e& Post=wor shop /ui8 to help people recognise what they have learnt from the wor shop and any outstanding needs. This will ta e about ? minutes. Evaluation form and certificate of attendance for use at group sessions. The evaluation form will ta e about ? minutes. Templates of the two=level 2VT and PE 4ells scores. These can be printed0 completed and added to patient records 2etails of further implementation tools accompanying the Venous thromboembolic diseases clinical guideline available from .'"E The duration of the wor shop can be tailored by ad>usting the number of cases considered and by underta ing some follow=up tas s by email. 'f all the components are used the wor shop will ta e about $ hour %* minutes.
Page % of )$
!earning ob"ectives
Participants will: become familiar with the diagnosis algorithm for PE understand the possible treatment options for PE and when these treatment options are recommended become familiar with the information patients re/uire understand when it is appropriate to initiate cancer screening and thrombophilia testing in patients with VTE.
#ey to terms
The following terms are used in this training plan and the clinical guideline. International normalised ratio $IN%& 7 standardised laboratory measure of blood coagulation used to monitor the ade/uacy of anticoagulation in patients who are having treatment with a vitamin @ antagonist. 'rovoked deep vein thrombosis $(V)& or pulmonary embolism $'E& 2VT or PE in a patient with an antecedent (within - months& and transient ma>or clinical ris factor for VTE F for e1ample surgery0 trauma0 significant immobility (bedbound0 unable to wal unaided or li ely to spend a substantial proportion of the day in bed or in a chair&0 pregnancy or puerperium F or in a patient who is having hormonal therapy (oral contraceptive or hormone replacement therapy&. 'ro imal (V) 2VT in the popliteal vein or above. Pro1imal 2VT is sometimes referred to as above= nee 2VT. %enal impairment Geduced renal function that may be acute or chronic. 7n estimated glomerular filtration rate of less than C* ml!minute!$.A- m) indicates a degree of renal impairment in chronic idney disease. (Hor .'"E guidance on the classification
Page ? of )$
of chronic idney disease see "hronic idney disease I.'"E clinical guideline A-J&. *nprovoked (V) or 'E 2VT or PE in a patient with: no antecedent ma>or clinical ris factor for VTE (see Provo ed deep vein thrombosis or pulmonary embolism above& who is not having hormonal therapy (oral contraceptive or hormone replacement therapy& or active cancer0 thrombophilia or a family history of VTE0 because these are underlying ris s that remain constant in the patient. Wells scores "linical prediction rules for estimating the probability of 2VT and PE. There are a number of versions of 4ells scores available. This guideline recommends the two=level 2VT 4ells score and the two=level PE 4ells score.
Page D of )$
're+,orkshop -ui.
Pre- workshop quiz questions
/0 What is: A: VTE? B: DVT? C: PE? 10 !ist four ma"or risk factors for V)E diseases
20 'E is a treatable condition3 but ,hat patient outcomes can severe cases lead to?
40 Which groups of patients presenting ,ith 'E are at highest risk of increased mortality?
50 6ortality is significantly higher ,ith 'E than ,ith (V): True ! Halse
Page A of )$
Page B of )$
70 If left untreated ,hat is the prognosis for 'E? Poor = even when treated0 a small proportion of patients develop chronic thromboembolic pulmonary hypertension as a result of fibrotic0 occlusive organisation of thrombi or emboli and pulmonary vascular remodelling. 80 !ist four signs and symptoms of 'E 7ny four of the following: dyspnoea0 pleuritic chest pain (due to pleural irritation in pulmonary infarction&0 retrosternal chest pain (due to right ventricular ischaemia&0 cough and haemoptysis. 'n severe cases0 the right ventricle fails leading to di88iness and!or syncope. The signs include tachypnoea0 tachycardia0 hypo1ia0 pyre1ia0 elevated >ugular venous pressure0 a gallop rhythm0 a widely split second heart sound0 tricuspid regurgitant murmur0 pleural rub0 systemic hypotension and cardiogenic shoc .
Page C of )$
Page $* of )$
'ost+,orkshop -ui.
Post-workshop quiz questions
/0 In a patient in ,hom you suspect 'E ,ith a likely t,o+level 'E Wells score ,hat diagnostic investigations ,ould you offer?
10 In a patient in ,hom you suspect 'E ,ith an unlikely t,o+level 'E Wells score ,hat diagnostic investigations ,ould you offer?
20 When offering patients ,ith a diagnosis of 'E pharmacological treatment0 In ,hat clinical situations ,ould you not offer the recommended treatment of either !6WH or fondaparinu ?
40 When ,ould you offer patients ,ith 'E a Vitamin # ;ntagonist $such as ,arfarin& for more than 2 months?
5 a0 In ,hich people ,ith a diagnosis of 'E ,ould you consider investigations for cancer?
5 b0 If these are negative3 for ,hich patients ,ould you then consider further investigations3 and ,hich further investigations ,ould you offer?
Page $$ of )$
Page $) of )$
5 a0 In ,hich people ,ith a diagnosis of 'E ,ould you consider investigations for cancer? 'n people with a diagnosis of unprovo ed 2VT or PE offer physical e1amination0 chest M=ray0 bloods tests and urinalysis. Eee recommendation $.?.$ in the .'"E clinical guideline. 5 b0 If these are negative3 for ,hich patients ,ould you then consider further investigations3 and ,hich further investigations ,ould you offer? "onsider further investigations in patients older than %* with a first unprovo ed 2VT or PE who do not have signs or symptoms of cancer based on initial investigations. These further investigations should be: an abdomino=pelvic "T scan for all0 and also a mammogram for women. Eee recommendation $.?.) in the .'"E clinical guideline.
Page $- of )$
Evaluation form
'nsert date and time of wor shop: ;dministration The information you received before the wor shop was: Too much (ust right .ot enough 2ont now
The time allowed to complete the pre=wor shop tas s was: Too much Workshop <as the session improved your nowledge of the guidance3 Nes Partly .o 2ont now (ust right .ot enough 2ont now
'f not0 what were the reasons3 ............................................................................................................... ................ ............................................................................................................................... 2id the session e1plain how the guidance should be used3 Nes0 completely Partly .o 2ont now
'f not0 what were the reasons3 ............................................................................................................... ................ ............................................................................................................................... 4ere the case studies helpful3 Nes Partly .o 2ont now
4ill areas of your practice change as a result of this session3 'f so0 how and if not0 what are the reasons3 OOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO........ ............................................................................................................................... ............................................................................................................................... 2o you have any other comments or suggestions for improvement3 OOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO........ ...............................................................................................................................
Page $% of )$
Page $? of )$
Certificate of attendance
.................................................... completed a
on ................................... at ...................................
!igned............................................... "esignation..........................................
Page $D of )$
Page $A of )$
Clinical feature 7ctive cancer (treatment ongoing0 within D months0 or palliative& Paralysis0 paresis or recent plaster immobilisation of the lower e1tremities Gecently bedridden for - days or more or ma>or surgery within $) wee s re/uiring general or regional anaesthesia 6ocalised tenderness along the distribution of the deep venous system Entire leg swollen "alf swelling at least - cm larger than asymptomatic side Pitting oedema confined to the symptomatic leg "ollateral superficial veins (non=varicose& Previously documented 2VT 7n alternative diagnosis is at least as li ely as 2VT Clinical probability simplified score 2VT likely 2VT unlikely
'oints $ $ $ $ $ $ $ $ $ P)
'atient score
7dapted with permission from: = 4ells PE et al. ()**-& Evaluation of 2=dimer in the diagnosis of suspected deep=vein thrombosis. .ew England (ournal of 9edicine -%C: $))AF-? = The .ational "linical #uideline "entre
Template Two=level 2VT 4ells score Hrom .'"E clinical guideline $%% VTE diseases ((une )*$)&
Clinical feature "linical signs and symptoms of 2VT (minimum of leg swelling and pain with palpation of the deep veins& 7n alternative diagnosis is less li ely than PE <eart rate Q $** beats per minute 'mmobilisation for more than - days or surgery in the previous % wee s Previous 2VT!PE <aemoptysis 9alignancy (on treatment0 treated in the last D months0 or palliative& Clinical probability simplified scores PE likely PE unlikely
'atient score
7dapted with permission from = 4ells PE et al. ()***& 2erivation of a simple clinical model to categori8e patients probability of pulmonary embolism: increasing the models utility with the EimpliGE2 2= dimer. Thrombosis and <aemostasis B-: %$DF)* = The .ational "linical #uideline "entre
Template two=level PE 4ells score. Hrom .'"E clinical guideline $%% VTE diseases ((une )*$)&
NICE -uality standard for diagnosis and management of venous thromboembolic diseases
Published in 9arch )*$-. This /uality standard defines clinical best practice within this topic area. 't provides specific0 concise /uality statements0 measures and audience descriptors to provide the public0 health and social care professionals0 commissioners and service providers with definitions of high= /uality care. This /uality standard covers the diagnosis and treatment of venous thromboembolic diseases in adults0 e1cluding pregnant women.
;ckno,ledgements
.'"E would li e to than the .ational "linical #uideline "entre and the #uideline 2evelopment #roup0 especially #erard Etansby0 Professor of Vascular Eurgery0 Hreeman <ospital and .ewcastle +niversity Eusan :allard 2avid :erridge0 "onsultant Vascular Eurgeon0 6eeds #eneral 'nfirmary Gichard 2ay0 "onsultant Physician (#eriatrics&0 Poole <ospital .<E Houndation Trust :everley <unt0 Professor of Thrombosis and <aemostasis0 @ings "ollege0 6ondon and 9edical 2irector of 6ifeblood
Page )* of )$
2avid @eeling0 "onsultant <aematologist0 ,1ford +niversity <ospitals .<E Trust Eteven 9oser0 "onsultant Gadiologist0 'mperial "ollege <ealthcare .<E Trust0 6ondon @aren Eheares0 Gespiratory "onsultant with an interest in pulmonary vascular diseases0 Papworth <ospital .<E Houndation Trust
Page )$ of )$